98%
921
2 minutes
20
The increasing prevalence of central nervous system (CNS) disorders has imposed a significant social and economic burden on healthcare systems. The blood-brain barrier (BBB) presents a major challenge for effective drug delivery to the brain, hindering disease treatment advancements. The BBB consists of various cell types, including microvascular endothelial cells and astrocytes, with tight junctions playing a key role in regulating molecular exchange and maintaining brain homeostasis. However, current research on the mechanical properties of the BBB mainly focuses on individual cellular components or the vasculature as a whole, with limited attention to the mechanical behavior of the tight junctions between these cells. This study develops a three-dimensional (3D) mechanical model of the BBB, incorporating tight junctions as membrane structures within the vessel wall. To simulate stress distribution within the BBB, tight junctions are described by a modified standard linear solid model, while the vessel wall is depicted by the Yeoh model. Parameters of the Yeoh model are optimized using machine learning algorithms based on experimental data. Then finite element simulations are conducted to analyze the stretching process of the BBB, yielding stress distributions and stress-strain relationships that elucidate the mechanical properties of the BBB under tensile conditions. The influences of the cell membrane elastic modulus, elastic modulus of the cytoskeleton and cytoplasmic viscosity in the modified standard linear solid model on the maximum stress in the tight junction at equilibrium are intensively discussed. These findings provide theoretical insights into the understanding of CNS disorders and have potential applications in drug delivery strategies.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jbiomech.2025.112777 | DOI Listing |
FEBS Open Bio
September 2025
Graduate School of Pharmaceutical Sciences, The University of Osaka, Suita, Japan.
Tight junctions (TJs) are formed where two or three cells meet and are therefore categorized, respectively, into bicellular TJs (bTJs) and tricellular TJs (tTJs). Angubindin-1 is the first tTJ modulator enhancing intestinal macromolecule permeation via binding to the key tTJ proteins, angulin-1 and angulin-3. It is a fragment (amino acids 421-664) derived from domain IV of Clostridium perfringens iota toxin.
View Article and Find Full Text PDFJ Exp Pharmacol
September 2025
Department of Translational Medicine, University of Ferrara, Ferrara, Italy.
Purpose: Acute graft-versus-host disease (aGVHD) is a significant cause of death in recipients of allogeneic hematopoietic stem cell transplantation. In this type of graft, the intestine is particularly affected, with the loss of intestinal barrier integrity playing a key role in its onset. In this scenario, the aim of the present research was to evaluate defibrotide, a heparin-like compound, marked for severe veno-occlusive disease, as an innovative therapeutic approach for restoring intestinal barrier integrity using an in vitro model and analyzing aGVHD patients' sera and clinical data.
View Article and Find Full Text PDFPLoS One
September 2025
Advanced Radiation Technology Institute, Korea Atomic Energy Research Institute, Jeongeup, Republic of Korea.
The oral epithelial barrier plays a crucial role in maintaining oral health by protecting against microbial invasion and mechanical stress while regulating selective permeability. Disruption of this barrier contributes to inflammation and the development of oral diseases such as gingivitis and periodontitis. Pinoresinol, a lignan with antioxidant, antimicrobial, and anti-inflammatory properties, has demonstrated health benefits in systemic diseases; however, its effects on oral epithelial barrier integrity remain unclear.
View Article and Find Full Text PDFJ Control Release
September 2025
Department of Pharmaceutics, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou City, Zhejiang Province 325035, China. Electronic address:
Gut barrier loss exacerbated gut microbiota dysbiosis by permitting pathogenic blooms, while gut microbiota dysbiosis caused the development of gut mucosal wounds by reducing mucus and breaking down epithelial tight junction. Current therapies combating colitis often fail to address both gut barrier dysfunction and microbial imbalance. Herein, inspired by natural gut mucus, a dual-crosslinked hydrogel (HSMP-LA) composed of thiol/maleimide-modified hyaluronic acid together with co-loading of antimicrobial ε-polylysine (ε-PL) and larazotide acetate (LA) had been developed as an injectable artificial gut mucus to simultaneously restore barrier integrity and modulate gut microbiota.
View Article and Find Full Text PDFEndocr Metab Immune Disord Drug Targets
August 2025
Department of Gastrointestinal Surgery, The Wujin Hospital Affiliated with Jiangsu University, Changzhou, China.
Introduction: Celiac Disease (CeD) is a serious, lifelong autoimmune condition. There remains a significant unmet medical need for effective pharmacological treatments for CeD.
Methods: We utilized summary statistics for 2,888 druggable genes from the eQTLGen Consortium and the FinnGen Consortium for CeD.